Literature DB >> 8491226

A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine.

F Chen1, C Decristoforo, B Rohrbacher, G Riccabona.   

Abstract

Technetium-99m mercaptoacetyltriglycine (MAG3) has been used extensively as a renal function agent for several years. Radioimpurities in the MAG3 kit preparation are not only concentrated and excreted in the kidneys. Therefore proper quality control for renal studies is even more important to make possible a rapid and adequate interpretation of diagnostic studies. The standard method to determine the radiochemical purity is high-performance liquid chromatography (HPLC), which is time consuming and expensive. We set up a new simple thin-layer chromatography (TLC) method based on instant thin-layer silica gel strips as stationary phase for checking the main impurities, free pertechnetate and reduced hydrolysed 99mTc-colloid. Comparison of TLC and HPLC results showed no significant differences (t-test, P < 0.05); the correlation between the results obtained with the two methods in respect of the free pertechnetate content was excellent (r = 0.99913). The TLC method was also efficient in determining the percentage of 99mTc-colloid. The main impurity found in 37 routine preparations was free pertechnetate; the mean radiochemical purity was 97.95%. The time required to perform the analysis was less than 20 min. The new TLC system is a cheap, simple, fast, reliable and accurate method for the quality control of the MAG3 kit preparation, and is especially suitable for routine use.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491226     DOI: 10.1007/BF00169810

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.

Authors:  J R Coveney; M S Robbins
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

2.  Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure.

Authors:  A Taylor; D Eshima; P E Christian; W W Wooten; L Hansen; K McElvany
Journal:  J Nucl Med       Date:  1988-05       Impact factor: 10.057

3.  Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

Authors:  A R Fritzberg; S Kasina; D Eshima; D L Johnson
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

4.  Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.

Authors:  W Brandau; B Bubeck; M Eisenhut; D M Taylor
Journal:  Int J Rad Appl Instrum A       Date:  1988
  4 in total
  2 in total

1.  A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine (99mTc-MAG3).

Authors:  Marietta Straub; Michel Leresche; Claude Pilloud; Fabien Devynck; Nicolas Stritt; Rolf Hesselmann
Journal:  EJNMMI Radiopharm Chem       Date:  2018-03-14

2.  Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures.

Authors:  Claudio Maioli; Giovanni Luciniani; Aldo Strinchini; Luca Tagliabue; Angelo Del Sole
Journal:  Acta Biomed       Date:  2017-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.